Healthcare is outperforming the S&P 500. While the broader market barely touched its gap, the healthcare sector blew right through it and kept climbing.
Blake Young spotted this divergence today. He found five dividend-paying stocks positioned for both income and breakout gains.
The setup is straightforward. Market volatility is rising. Option spreads are widening. Market makers are charging more to hedge risk.
Blake’s response: hunt for lower beta names that pay you while you wait.
In tonight’s video, Blake walks through specific trades in healthcare:
- Pfizer showing a monkey bar breakout with a 6.5% dividend yield and targets of $26.60 to $27.50
- GlaxoSmithKline offering a potential 8-10% return in two months between the put premium, dividend, and price move to $50.68
- Merck holding near all-time highs while paying a 3.11% dividend with 10% upside if it breaks free
- Amgen closing above previous resistance at new record highs with a 2.9% dividend
- Medtronic setting up for a 5-6% move to new annual highs at $107 with a 2.8% dividend
The strategy targets established pharmaceutical companies rather than biotech names. No surprise FDA approvals or rejections to worry about.
If you want income while you wait for direction, this is the sector to watch.
